Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Programmed death ligand 1 signals in cancer cells.
Kornepati AVR, Vadlamudi RK, Curiel TJ. Kornepati AVR, et al. Among authors: curiel tj. Nat Rev Cancer. 2022 Mar;22(3):174-189. doi: 10.1038/s41568-021-00431-4. Epub 2022 Jan 14. Nat Rev Cancer. 2022. PMID: 35031777 Free PMC article. Review.
Regulatory T cells and treatment of cancer.
Curiel TJ. Curiel TJ. Curr Opin Immunol. 2008 Apr;20(2):241-6. doi: 10.1016/j.coi.2008.04.008. Epub 2008 May 27. Curr Opin Immunol. 2008. PMID: 18508251 Free PMC article. Review.
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.
Lin PY, Sun L, Thibodeaux SR, Ludwig SM, Vadlamudi RK, Hurez VJ, Bahar R, Kious MJ, Livi CB, Wall SR, Chen L, Zhang B, Shin T, Curiel TJ. Lin PY, et al. Among authors: curiel tj. J Immunol. 2010 Sep 1;185(5):2747-53. doi: 10.4049/jimmunol.1000496. Epub 2010 Aug 4. J Immunol. 2010. PMID: 20686128 Free PMC article.
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Chakravarty D, et al. Among authors: curiel tj. Clin Cancer Res. 2011 Apr 15;17(8):2250-9. doi: 10.1158/1078-0432.CCR-10-2718. Epub 2011 Mar 18. Clin Cancer Res. 2011. PMID: 21421858 Free PMC article.
Immune therapy for ovarian cancer: promise and pitfalls.
Thibodeaux SR, Curiel TJ. Thibodeaux SR, et al. Among authors: curiel tj. Int Rev Immunol. 2011 Apr-Jun;30(2-3):102-19. doi: 10.3109/08830185.2011.567361. Int Rev Immunol. 2011. PMID: 21557637 Review.
Immunotherapy for ovarian cancer.
Drerup JM, Liu Y, Padron AS, Murthy K, Hurez V, Zhang B, Curiel TJ. Drerup JM, et al. Among authors: curiel tj. Curr Treat Options Oncol. 2015 Jan;16(1):317. doi: 10.1007/s11864-014-0317-1. Curr Treat Options Oncol. 2015. PMID: 25648541 Free PMC article. Review.
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.
Massard C, Gordon MS, Sharma S, Rafii S, Wainberg ZA, Luke J, Curiel TJ, Colon-Otero G, Hamid O, Sanborn RE, O'Donnell PH, Drakaki A, Tan W, Kurland JF, Rebelatto MC, Jin X, Blake-Haskins JA, Gupta A, Segal NH. Massard C, et al. Among authors: curiel tj. J Clin Oncol. 2016 Sep 10;34(26):3119-25. doi: 10.1200/JCO.2016.67.9761. Epub 2016 Jun 6. J Clin Oncol. 2016. PMID: 27269937 Free PMC article. Clinical Trial.
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.
Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, Drerup JM, Padron A, Conejo-Garcia J, Murthy K, Liu Y, Turk MJ, Thedieck K, Hurez V, Li R, Vadlamudi R, Curiel TJ. Clark CA, et al. Among authors: curiel tj. Cancer Res. 2016 Dec 1;76(23):6964-6974. doi: 10.1158/0008-5472.CAN-16-0258. Epub 2016 Sep 26. Cancer Res. 2016. PMID: 27671674 Free PMC article.
162 results